SMAD2 and hereditary spastic paraplegia: By downregulating the expression of transforming growth factor-β1 and its downstream mediators (e.g., Smad2/3 phosphorylation), HSP may attenuate fibroblast-to-myofibroblast differentiation and reduce collagen accumulation.